Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DOS-47 demonstrates preclinical antitumor activity

Sep. 17, 2003

Market launch announced for Aloxi

Sep. 16, 2003

Advisory committee does not recommend approval of Metvix for basal cell carcinoma

Sep. 16, 2003

Bioenvision obtains clofarabine option in Japan and South East Asia

Sep. 16, 2003

Philip Morris grant supports TNT-based lung cancer research

Sep. 16, 2003

Vitaxin enters phase II trials in melanoma and rheumatoid arthritis

Sep. 16, 2003

Antisoma licenses telomerase inhibitor program

Sep. 16, 2003

Kinase inhibitors under study at Bayer

Sep. 16, 2003

Preclinical results reported for AZ-CINN-310 in breast cancer

Sep. 16, 2003

Phase III results for Genasense plus chemotherapy in malignant melanoma

Sep. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...